Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down‐regulating EGFR expression

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|15|3817-3830

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.15, 2015-08, pp. : 3817-3830

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell Growth Inhibition and Gene Expression Induced by the Histone Deacetylase Inhibitor, Trichostatin A, on Human Hepatoma Cells

By  

Oncology, Vol. 66, Iss. 6, 2004-09 ,pp. : 481-491

Karger

Access to resources Recommend Favorite

Trastuzumab enhances the anti-tumor effects of the histone deacetylase inhibitor sodium butyrate on a HER2-overexpressing breast cancer cell line

By              

International Journal of Molecular Medicine, Vol. 28, Iss. 6, 2011-01 ,pp. : 985-991

Spandidos Publications

Access to resources Recommend Favorite

Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data

By Truong Thach-Giao   Munster Pamela  

Clinical Investigation, Vol. 3, Iss. 6, 2013-06 ,pp. : 557-569

Future Science

Access to resources Recommend Favorite

Entinostat, a novel histone deacetylase inhibitor is active in B‐cell lymphoma and enhances the anti‐tumour activity of rituximab and chemotherapy agents

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 4, 2015-05 ,pp. : 506-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel Histone Deacetylase Inhibitor Reduces Abdominal Aortic Aneurysm Formation in Angiotensin II-Infused Apolipoprotein E-Deficient Mice

By  

Journal of Vascular Research, Vol. 45, Iss. 2, 2007-10 ,pp. : 143-152

Karger

Access to resources Recommend Favorite